Following his PhD, Naismith did
postdoctoral research at the
University of Texas Southwestern Medical Center as a
NATO Fellow in the laboratory of Stephen Sprang. He was appointed a lecturer at the
University of St Andrews in 1995,
Reader in 1999 and a Professor in 2001. Naismith's research investigates: His research has been funded by the
Biotechnology and Biological Sciences Research Council (BBSRC), the
Engineering and Physical Sciences Research Council (EPSRC), the
Medical Research Council (MRC), the
Wellcome Trust and the
European Union. Naismith joined the University of Oxford in 2017 as Professor of Structural Biology in the Nuffield Department of Medicine and Senior Research Fellow at
Jesus College. He directed the Research Complex at Harwell between 2017 and 2019 and the Rosalind Franklin Institute from 2018.
Awards and honours Naismith was awarded the 2000 Dextra Carbohydrate award and the 2009 Jeremy Knowles Prize in Chemical Biology both from the
Royal Society of Chemistry. Naismith was elected a
Fellow of the Royal Society (FRS) in 2014. His nomination reads: Naismith was part of the team awarded a 2022
Royal Society of Chemistry Horizon Prize for their work on
nanobodies against
Covid19. Naismith is also
Fellow of the Royal Society of Chemistry (FRSC), the
Royal Society of Biology (FRSB), the
Royal Society of Edinburgh (FRSE), the
Academy of Medical Sciences, United Kingdom (FMedSci), an elected member of the
European Molecular Biology Organization (EMBO), in 2016 was elected a
Fellow of the American Association for the Advancement of Science (AAAS) and in 2022 elected a member of Academia Europaea (AE). His nomination for the Academy of Medical Sciences reads: ==Personal life==